Mind Medicine (MindMed) Inc.

MNMDNASDAQHealthcare

$20.69

+$0.09(+0.44%)

Market Cap$1.6B

P/E Ratio—

52W High$21.08

52W Low$4.7

Avg Volume2.5M

Open$20.15

Beta2.62

Forecast Market Cap PE Ratio

Mind Medicine (MindMed) Inc.（MNMD）股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

mnmd · 股价预测 · 1 位分析师（近3月）· FMP · 更新于 2026年4月3日

分析师评级与共识

基于过去 3 个月内 1 位华尔街分析师

Buy

1 位分析师

共识

评级分布

Strong Buy

Buy

Hold

Sell

Strong Sell

合计: 1 · 买入占比: 100.0%

12 个月目标价

High

$28.00

Consensus

$20.00

-8.6% upside

Low

$14.00

Median: $20 · Last Close: $21.88

Mind Medicine (MindMed) Inc.（MNMD）的分析师共识为 Buy，基于过去 3 个月内 1 位华尔街分析师的评级。MNMD 的 12 个月平均目标价为 $20.00，相对当前价 $21.88 代表 -8.6% 的潜在上行空间。

12 个月目标价预测

历史收盘价 + 分析师 12 个月目标价预测区间

Historical priceConsensus $20 (-8.6%)High $28Low $14

Consensus Target

$20.00

-8.6% upside

High Target

$28

28.0%

Low Target

$14

-36.0%

Current Price

$21.88

as of today

Based on analyst price targets, the MNMD stock price prediction for the next 12 months ranges from $14 to $28. The consensus MNMD price forecast of $20.00 implies -8.6% upside from the current price of $21.88.

短期股价预测

Bull

算法生成 · 每日更新

Date	Predicted Price	Change	Min	Max
2026-06-09	$21.45	↓ 1.95%	$21.31	$21.59

1-day model range: $21.31–$21.59. Peak: $21.59 (-1.95%).

长期股价预测

年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031

Year	Low	Avg Price	High	Change
2027	$36	$38	$39	+71.8%
2028	$50	$52	$55	+139.7%
2029	$60	$64	$68	+191.7%
2030	$66	$71	$77	+226.6%
2031	$70	—	$82	+248.0%

Confidence:Medium

基于技术分析的股价预测

14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明

Market Sentiment

BULLISH

Based on 14 technical indicators

86%7%7%

12Buy

1Neutral

1Sell

RSI (14)52.0Neutral

MACDBULLISH

Refreshes daily from EOD close

Moving Averages · MNMD · Jun 8, 2026

Simple Moving Average (SMA)

MA 5$21.42BUY

MA 10$22.31SELL

MA 20$21.88BUY

MA 50$19.56BUY

MA 100$17.24BUY

MA 200$14.03BUY

Current $MNMD · Price above MA = BUY signal

Exponential Moving Average (EMA)

EMA 5$21.59BUY

EMA 10$21.81BUY

EMA 20$21.47BUY

EMA 50$19.86BUY

EMA 100$17.75BUY

EMA 200$14.97BUY

Current $MNMD · Price above MA = BUY signal

How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

分析师推荐趋势

MNMD analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 0 per month.

财务预测：EPS 与营收一致预期

Revenue This Year

$17M

↓ 92.3% YoY

Revenue Next Year

$56M

↑ 236.0% YoY

EPS This Year

$-1.94

EPS Next Year

$-1.82

↓ 6.2% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast MNMD EPS of $-1.94 for the current fiscal year, based on estimates from 9 analysts. The MNMD revenue forecast is $17M for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

MNMD 股价预测由两类独立数据源支撑：来自 1 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。MNMD 的共识目标价为 $20.00（-8.6% 上行空间），分析师共识为 Buy。

MNMD 的短期预测（明日）为 $21.45（-1.95%）。 MNMD 对 2027 年的股价预测均值为 $38。 MNMD 对 2030 年的预测区间为 $66–$77。

Mind Medicine (MindMed) Inc. 在 NASDAQ 上市，代码 MNMD。MNMD 在 2027 年的整体展望偏积极，在覆盖分析师中约 100% 对应 Buy 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

常见问题

MNMD 预测 · 8 个问题

根据 1 位华尔街分析师，MNMD 的 12 个月平均目标价为 $20.00，最高 $28.00、最低 $14.00。若有图表，中位目标价可在上方查看。相对当前价 $21.88，隐含约 -8.6% 的上行空间。

MNMD 目标价MNMD 分析师目标价MNMD 12个月目标价目标价 MNMD

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.